» Articles » PMID: 36684043

Hsa_circ_0001658 Accelerates the Progression of Colorectal Cancer Through MiR-590-5p/METTL3 Regulatory Axis

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As reported, multiple circular RNAs (circRNAs) interfere with colorectal cancer (CRC) progression. Here, circRNA_0001658 (circ_0001658) is focused on studying how it works in CRC.

Aim: Clarify the expression pattern, biological function, and underlying mechanism of circ_0001658 of CRC tumorigenesis.

Methods: In CRC-related chip data retrieved using the database named Gene Expression Omnibus, different expressions of circRNAs between CRC and normal tissue samples were identified. Quantitative Real-time PCR and Western blot ensured the analysis on circ_0001658, microRNA-590-5P (miR-590-5p), and methyltransferase-like 3 (METTL3) mRNA expressions in tissues and cells. Cell counting kit-8 and flow cytometry were used to detect cell proliferation, apoptosis and migration. The targeting relations between circ_0001658, miR-590-5p, and METTL3 mRNA 3'-untranslated region were under the verification of bioinformatics prediction and dual luciferase-based reporter gene assays. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis were employed on the downstream targets of miR-590-5p using the Database for Annotation, Visualization and Integrated Discovery database.

Results: Circ_0001658 and METTL3 mRNA was elevated in CRC tissues and cells, whereas miR-590-5p was decreased. Circ_0001658 overexpression promoted the proliferation of HT29 cells, inhibited apoptosis, and accelerated the cell cycle. In SW480 cells, knocking down circ_0001658 had the opposite effect. Circ_0001658 could specifically bind to miR-590-5p and negatively modulate its expressions; METTL3 is a miR-590-5p target that can be positively regulated by circ 0001658. Circ 0001658 was inversely associated with miR-590-5p expression while positively with METTL3 expressions.

Conclusion: Circ_0001658 regulates the miR-590-5p/METTL 3-axis to increase CRC cell growth and decrease apoptosis.

Citing Articles

Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy.

Taha S, Karimi M, Mahdavi B, Yousefi Tehrani M, Bemani A, Kabirian S Epigenetics Chromatin. 2025; 18(1):3.

PMID: 39810224 PMC: 11734566. DOI: 10.1186/s13072-024-00560-8.


Modulation of host N6-methyladenosine modification by gut microbiota in colorectal cancer.

Jiang T, Wang H, Cheng W, Xie C World J Gastroenterol. 2024; 30(38):4175-4193.

PMID: 39493326 PMC: 11525875. DOI: 10.3748/wjg.v30.i38.4175.


Roles of circRNAs in the progression of colorectal cancer: novel strategies for detection and therapy.

Mao J, Lu Y Cancer Gene Ther. 2024; 31(6):831-841.

PMID: 38337038 DOI: 10.1038/s41417-024-00739-x.


Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics.

Liu H, Huang Y, Lu S, Yuan D, Liu J Open Life Sci. 2023; 18(1):20220586.

PMID: 36970605 PMC: 10037166. DOI: 10.1515/biol-2022-0586.

References
1.
Zeng C, Huang W, Li Y, Weng H . Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol. 2020; 13(1):117. PMC: 7457244. DOI: 10.1186/s13045-020-00951-w. View

2.
Yu X, Fu X, Zhang X, Bai C, Wang Y . Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis. Anticancer Drugs. 2021; 33(2):158-166. DOI: 10.1097/CAD.0000000000001257. View

3.
Zhou D, Tang W, Xu Y, Xu Y, Xu B, Fu S . METTL3/YTHDF2 m6A axis accelerates colorectal carcinogenesis through epigenetically suppressing YPEL5. Mol Oncol. 2021; 15(8):2172-2184. PMC: 8333777. DOI: 10.1002/1878-0261.12898. View

4.
Wang N, Lu K, Qu H, Wang H, Chen Y, Shan T . CircRBM33 regulates IL-6 to promote gastric cancer progression through targeting miR-149. Biomed Pharmacother. 2020; 125:109876. DOI: 10.1016/j.biopha.2020.109876. View

5.
Luo X, Liu Y, Li H, Cheng T, Wu J, Chen L . Hsa_circ_0013290 Acts as Cancer-Promoting Gene in Hepatocellular Carcinoma. Cancer Control. 2021; 28:10732748211055681. PMC: 8606922. DOI: 10.1177/10732748211055681. View